Ernst Rietzschel
Overview
Explore the profile of Ernst Rietzschel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
752
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parhofer K, Aguiar C, Banach M, Drexel H, Gouni-Berthold I, de Isla L, et al.
Eur Heart J Cardiovasc Pharmacother
. 2025 Mar;
PMID: 40052330
The clinically important link between low-density lipoprotein cholesterol (LDL-C) lowering and cardiovascular (CV) risk reduction is well-established and reflected in the 2019 European Society of Cardiology/European Atherosclerosis Society guidelines for...
2.
Gan S, Azzo J, Zhao L, Pourmussa B, Dib M, Salman O, et al.
Circ Heart Fail
. 2025 Jan;
18(2):e011728.
PMID: 39831311
Background: Iron deficiency (ID) is currently defined as a serum ferritin level <100 or 100 to 299 ng/mL with transferrin saturation (TSAT) <20%. Serum ferritin and TSAT are currently used...
3.
Dib M, Azzo J, Zhao L, Salman O, Gan S, De Buyzere M, et al.
JACC Basic Transl Sci
. 2024 Nov;
9(10):1178-1191.
PMID: 39534640
The molecular mechanisms contributing to large artery stiffness (LAS) are not fully understood. The aim of this study was to investigate the association between circulating plasma proteins and LAS using...
4.
Salman O, Zhao L, Cohen J, Dib M, Azzo J, Gan S, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e033660.
PMID: 39206761
Background: Kidney disease is common in heart failure with preserved ejection fraction (HFpEF). However, the biologic correlates and prognostic significance of kidney injury (KI), in HFpEF, beyond the estimated glomerular...
5.
Salman O, Zamani P, Zhao L, Dib M, Gan S, Azzo J, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e033675.
PMID: 39206715
Background: The role of cellular senescence in human heart failure (HF) remains unclear. The senescence-associated secretory phenotype (SASP) is composed of proteins released by senescent cells. We assessed the prognostic...
6.
Ray K, Aguiar C, Arca M, Connolly D, Eriksson M, Ferrieres J, et al.
Eur J Prev Cardiol
. 2024 Jun;
31(15):1792-1803.
PMID: 38861400
Aims: To assess whether implementation of the 2019 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) dyslipidaemia guidelines observed between 2020 and 2021 improved between 2021 and 2022 in the...
7.
Carland C, Zhao L, Salman O, Cohen J, Zamani P, Xiao Q, et al.
J Am Heart Assoc
. 2024 Apr;
13(9):e033410.
PMID: 38639358
Background: Although several studies have addressed plasma proteomics in heart failure with preserved ejection fraction, limited data are available on the prognostic value of urinary proteomics. The objective of our...
8.
Steenkamer B, Vaes B, Rietzschel E, Crombez J, de Geest S, Demeure F, et al.
BMC Health Serv Res
. 2023 Jun;
23(1):659.
PMID: 37340416
Background: Although there are already success stories, population health management in Belgium is still in its infancy. A health system transformation approach such as population health management may be suited...
9.
Ray K, Haq I, Bilitou A, Manu M, Burden A, Aguiar C, et al.
Lancet Reg Health Eur
. 2023 Apr;
29:100624.
PMID: 37090089
Background: European data pre-2019 suggest statin monotherapy is the most common approach to lipid management for preventing cardiovascular (CV) events, resulting in only one-fifth of high- and very high-risk patients...
10.
Ray K, Haq I, Bilitou A, Aguiar C, Arca M, Connolly D, et al.
Atheroscler Plus
. 2023 Jan;
43:24-30.
PMID: 36644508
Background And Aims: Clinical practice before 2019 suggests a substantial proportion of high and very high CV risk patients taking lipid-lowering therapy (LLT) would not achieve the new LDL-C goals...